Cancer BiologyCancer ResearchPeer-reviewed
"3G" Trial: An RNA Editing Signature for Guiding Gastric Cancer Chemotherapy
O. An, Y. Song, X. Ke…·Singapore Gastric Cancer Consortium (SGCC)
The paper develops an RNA editing signature (GCRE) to predict chemotherapy response in gastric cancer, achieving 84% accuracy and showing better outcomes in patients with higher editing levels.
DOI 10.1158/0008-5472.can-20-2872